Age, biological sex, and human genetic factors influence the production of antibodies during the immune response. A team of scientists from the Institut Pasteur, the CNRS and the Collège de France ...

An analysis of antibody responses to more than 90,000 viral protein fragments shows that age, biological sex, and genetic ...

A new artificial intelligence-driven pipeline developed in a collaborative research combines protein structure prediction, sequence design, and live-cell screening together to enable rapid conversion ...

Monoclonal antibodies (mAbs) have been a key therapeutic option for non-communicable diseases for decades, and a small number of mAbs have helped treat infectious diseases, including COVID-19. The ...

Researchers create nanomachines using metal and polyphenols, which enhance targeted intracellular delivery of antibodies for cancer therapy. Antibodies are Y-shaped proteins produced by the body’s ...

ADCs integrate monoclonal antibodies with cytotoxic payloads, offering new treatment options for NSCLC, including biomarker-selected and biomarker-agnostic patients. ADCs are composed of an antibody, ...

Discover how Catalent's Rapid Antibody platform delivers GMP drug substance in 8 months, accelerating mAb development from gene construct to IND readiness.

Antibody production is crucial in the fight against viruses. But its levels in the body are determined by age, sex, and human ...